Literature DB >> 6373159

Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects.

E Bonora, M Cigolini, O Bosello, C Zancanaro, L Capretti, I Zavaroni, C Coscelli, U Butturini.   

Abstract

A study was carried out to evaluate the acute effect of an intravenous injection of metformin on the fasting plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in 15 non-diabetic subjects. Metformin (1 g) was administered as a bolus in a peripheral vein and blood was sampled 2, 5, 10, 15 and 30 minutes after the drug injection. No significant change in fasting concentration of glucose nor in C-peptide, insulin, glucagon and growth hormone fasting levels was noticed. It is concluded that metformin does not possess an acute direct hypoglycaemic effect in non-diabetic subjects and does not acutely affect the basal activity of endocrine pancreas and pituitary gland in releasing insulin, glucagon and growth hormone.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6373159     DOI: 10.1185/03007998409109558

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  32 in total

1.  Endogenous glucose production increases in response to metformin treatment in the glycogen-depleted state in humans: a randomised trial.

Authors:  Mette Marie H Christensen; Kurt Højlund; Ole Hother-Nielsen; Tore B Stage; Per Damkier; Henning Beck-Nielsen; Kim Brøsen
Journal:  Diabetologia       Date:  2015-08-14       Impact factor: 10.122

Review 2.  Metformin: New Preparations and Nonglycemic Benefits.

Authors:  Yoshihito Fujita; Nobuya Inagaki
Journal:  Curr Diab Rep       Date:  2017-01       Impact factor: 4.810

3.  Worsening Glycemia Increases the Odds of Intermittent but Not Persistent Staphylococcus aureus Nasal Carriage in Two Cohorts of Mexican American Adults.

Authors:  Heather T Essigmann; Craig L Hanis; Stacia M DeSantis; William B Perkison; David A Aguilar; Goo Jun; D Ashley Robinson; Eric L Brown
Journal:  Microbiol Spectr       Date:  2022-05-18

4.  Metformin Influence on the Intestinal Microbiota and Organism of Rats with Metabolic Syndrome.

Authors:  Elena Ermolenko; Anna Simanenkova; Lyubov Voropaeva; Nadezhda Lavrenova; Maryna Kotyleva; Sarkis Minasian; Alena Chernikova; Natalya Timkina; Nikita Gladyshev; Alexander Dmitriev; Alexander Suvorov; Michael Galagudza; Tatiana Karonova
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

Review 5.  Gut microorganisms as promising targets for the management of type 2 diabetes.

Authors:  Nathalie M Delzenne; Patrice D Cani; Amandine Everard; Audrey M Neyrinck; Laure B Bindels
Journal:  Diabetologia       Date:  2015-07-31       Impact factor: 10.122

Review 6.  Metformin, Microbiome and Protection Against Colorectal Cancer.

Authors:  Georgina R Jones; Mark P Molloy
Journal:  Dig Dis Sci       Date:  2020-06-12       Impact factor: 3.199

7.  Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.

Authors:  Antonella Napolitano; Sam Miller; Andrew W Nicholls; David Baker; Stephanie Van Horn; Elizabeth Thomas; Deepak Rajpal; Aaron Spivak; James R Brown; Derek J Nunez
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

Review 8.  Repurposing metformin: an old drug with new tricks in its binding pockets.

Authors:  Rosina Pryor; Filipe Cabreiro
Journal:  Biochem J       Date:  2015-11-01       Impact factor: 3.857

Review 9.  New Aspects of Diabetes Research and Therapeutic Development.

Authors:  Leslie S Satin; Scott A Soleimanpour; Emily M Walker
Journal:  Pharmacol Rev       Date:  2021-07       Impact factor: 18.923

10.  Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials.

Authors:  Ralph A DeFronzo; John B Buse; Terri Kim; Colleen Burns; Sharon Skare; Alain Baron; Mark Fineman
Journal:  Diabetologia       Date:  2016-05-23       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.